Application 020710

Type
NDA
Sponsor
APOTEX TECHNOLOGIES

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PAXILPAROXETINE HYDROCHLORIDESUSPENSION;ORALEQ 10MG BASE/5MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent
60505-0402PAXILparoxetine hydrochlorideApotex CorpNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80480SUPPL 2024-12-03
80459SUPPL 2024-12-02
80458SUPPL 2024-12-02
68844SUPPL2021-10-01
68843SUPPL2021-10-01
68727SUPPL2021-09-23
66804SUPPL2021-03-18
66803SUPPL2021-03-18
66135SUPPL2021-02-09
46814SUPPL2017-01-13
46813SUPPL2017-01-13
46695SUPPL2017-01-06
13262SUPPL2014-07-29
25596SUPPL2014-07-23
13260SUPPL2012-12-31
3161SUPPL2012-12-21
35194SUPPL2012-04-17
3162SUPPL2012-04-12
41603SUPPL2011-12-09
41602SUPPL2011-12-09
41601SUPPL2011-12-09
13259SUPPL2011-07-12
13258SUPPL2011-07-12
3160SUPPL2011-07-12
3156SUPPL2011-07-12
35193SUPPL2011-03-28
35191SUPPL2011-03-28
13261SUPPL2011-03-28
25595SUPPL2011-03-24
3159SUPPL2011-03-24
3158SUPPL2011-03-24
25594SUPPL2010-11-02
35192SUPPL2010-10-28
25592SUPPL2009-11-19
35188SUPPL2009-11-05
35190SUPPL2009-02-04
25593SUPPL2009-02-03
35189SUPPL2008-11-07
3157SUPPL2008-11-03
41600SUPPL2007-09-24
41599SUPPL2007-09-24
20867SUPPL2007-09-24
25590SUPPL2007-08-07
35187SUPPL2007-08-03
25591SUPPL2006-09-20
3155SUPPL2006-09-20
25589SUPPL2006-02-08
3154SUPPL2006-02-08
44067ORIG2005-08-01